Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Igf1 , insulin-like growth factor 1
Additionally, for the following three drug categories: antibiotics/anti-infectives, blood thinners and drugs known to have low EAP approval rates there will be a six-month transitional period (until June 30, 2018), during which time insurers that are members of CLHIA will be the first payer for certain drugs that are not on ODBs formulary, without requiring proof that EAP coverage has been denied
Chia CW, Egan JM
FOR DULAGLUTIDE SOURCE: MedlinePlus
US$ 22.31
US$ 21.75
US$ 24.32
US$ 28.67
US$ 22.07
